Work

Phase II Study of Mega-Dose 90Y-Ibritumomab Tiuxetan, Fludarabine and Low-Dose TBI Followed By Allogeneic Hematopoietic Transplantation for Relapsed or Refractory Aggressive Large B-Cell Lymphoma: Long-Term Outcomes

Year: 2021

Type: article

Source: Transplantation and Cellular Therapy

DOI: 10.1016/s2666-6367(21)00510-8

Authors: Victor A. Chow, Ryan D. Cassaday, Ted A. Gooley, Brenda M. Sandmaier, Stephen D. Smith, Damian J. Green, Johnnie J. Orozco, Sherilyn A. Tuazon, Manuela C. Matesan, Oliver W. Press, Ajay K. Gopal

Institution: Oregon Health & Science University

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,650

OpenAlex ID: W3126414915

FWCI:

Cites:

Cited by:

Related to: 10